Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deaf-Blind Disorders, Deafness, Ear Diseases, Eye Diseases, Hereditary, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Rod-Cone Dystrophy, Sensation Disorders, Signs and Symptoms, Usher syndrome, blindness (disorder), cone-rod dystrophy, eye disorder, hearing disorder, hearing loss disorder, hereditary disease, inherited retinal dystrophy, nervous system disorder, otorhinolaryngologic disease, retinal degeneration, retinal disorder, retinitis pigmentosa, vision disorderRecruitingPhase 1 / Phase 22026-08-19NCT06789445

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bayer178
BlueRock Therapeutics4

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Mid Atlantic Retina/ Wills EyePhiladelphiaUnited States1
Retina Foundation of the SouthwestDallasUnited States38
University of Miami, Bascom Palmer Eye InstituteMiamiUnited States3
University of Southern California /Children's Hospital of Los AngelesLos AngelesUnited States1
University of WisconsinMadisonUnited States64